Literature DB >> 30506747

Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes.

Nan Chen1, J Jack Lee1.   

Abstract

Bayesian hierarchical models have been applied in clinical trials to allow for information sharing across subgroups. Traditional Bayesian hierarchical models do not have subgroup classifications; thus, information is shared across all subgroups. When the difference between subgroups is large, it suggests that the subgroups belong to different clusters. In that case, placing all subgroups in one pool and borrowing information across all subgroups can result in substantial bias for the subgroups with strong borrowing, or a lack of efficiency gain with weak borrowing. To resolve this difficulty, we propose a hierarchical Bayesian classification and information sharing (BaCIS) model for the design of multigroup phase II clinical trials with binary outcomes. We introduce subgroup classification into the hierarchical model. Subgroups are classified into two clusters on the basis of their outcomes mimicking the hypothesis testing framework. Subsequently, information sharing takes place within subgroups in the same cluster, rather than across all subgroups. This method can be applied to the design and analysis of multigroup clinical trials with binary outcomes. Compared to the traditional hierarchical models, better operating characteristics are obtained with the BaCIS model under various scenarios.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  classification; clinical trial design; hierarchical model; information borrowing; multigroup phase II trial; subgroup analysis

Mesh:

Year:  2018        PMID: 30506747      PMCID: PMC6546564          DOI: 10.1002/bimj.201700275

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  24 in total

1.  Robust exchangeability designs for early phase clinical trials with multiple strata.

Authors:  Beat Neuenschwander; Simon Wandel; Satrajit Roychoudhury; Stuart Bailey
Journal:  Pharm Stat       Date:  2015-12-18       Impact factor: 1.894

2.  Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.

Authors:  Ariel Lopez-Chavez; Anish Thomas; Arun Rajan; Mark Raffeld; Betsy Morrow; Ronan Kelly; Corey Allan Carter; Udayan Guha; Keith Killian; Christopher C Lau; Zied Abdullaev; Liqiang Xi; Svetlana Pack; Paul S Meltzer; Christopher L Corless; Alan Sandler; Carol Beadling; Andrea Warrick; David J Liewehr; Seth M Steinberg; Arlene Berman; Austin Doyle; Eva Szabo; Yisong Wang; Giuseppe Giaccone
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

3.  Determining the effective sample size of a parametric prior.

Authors:  Satoshi Morita; Peter F Thall; Peter Müller
Journal:  Biometrics       Date:  2007-08-30       Impact factor: 2.571

4.  Bayesian Baskets: A Novel Design for Biomarker-Based Clinical Trials.

Authors:  Lorenzo Trippa; Brian Michael Alexander
Journal:  J Clin Oncol       Date:  2017-01-03       Impact factor: 44.544

5.  Bayesian response-adaptive designs for basket trials.

Authors:  Steffen Ventz; William T Barry; Giovanni Parmigiani; Lorenzo Trippa
Journal:  Biometrics       Date:  2017-02-17       Impact factor: 2.571

Review 6.  Bayesian clinical trials in action.

Authors:  J Jack Lee; Caleb T Chu
Journal:  Stat Med       Date:  2012-06-18       Impact factor: 2.373

Review 7.  Bayesian clinical trials.

Authors:  Donald A Berry
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

8.  A Bayesian semiparametric joint hierarchical model for longitudinal and survival data.

Authors:  Elizabeth R Brown; Joseph G Ibrahim
Journal:  Biometrics       Date:  2003-06       Impact factor: 2.571

9.  Borrowing information across subgroups in phase II trials: is it useful?

Authors:  Boris Freidlin; Edward L Korn
Journal:  Clin Cancer Res       Date:  2013-01-09       Impact factor: 12.531

10.  Emerging landscape of oncogenic signatures across human cancers.

Authors:  Giovanni Ciriello; Martin L Miller; Bülent Arman Aksoy; Yasin Senbabaoglu; Nikolaus Schultz; Chris Sander
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

View more
  4 in total

1.  Borrowing Strength and Borrowing Index for Bayesian Hierarchical Models.

Authors:  Ganggang Xu; Huirong Zhu; J Jack Lee
Journal:  Comput Stat Data Anal       Date:  2020-04       Impact factor: 1.681

2.  Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy.

Authors:  Liyun Jiang; Ruobing Li; Fangrong Yan; Timothy A Yap; Ying Yuan
Journal:  Contemp Clin Trials       Date:  2021-03-10       Impact factor: 2.226

Review 3.  Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.

Authors:  Liwen Su; Xin Chen; Jingyi Zhang; Fangrong Yan
Journal:  JCO Precis Oncol       Date:  2022-03

4.  Subgroup-specific dose finding for phase I-II trials using Bayesian clustering.

Authors:  Alexandra Curtis; Brian Smith; Andrew G Chapple
Journal:  Stat Med       Date:  2022-04-16       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.